OR WAIT null SECS
March 26, 2018
The agreement gives IncoCell Tianjin, a wholly-owned subsidiary of China-based Boyalife Group, access to Cesca’s celluar processing contract development and manufacturing services.
March 23, 2018
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
March 22, 2018
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
March 19, 2018
Sartorius Stedim Biotech has launched a new automated parallel bioreactor system for perfusion culture.
Sartorius has delivered to ABL’s Strasbourg facility, a GMP viral vector manufacturing package solution that includes single-use bioreactors and an automation platform for normal flow filtration, tangential filtration, and mixing.
March 16, 2018
The contract development and manufacturing organization has expanded biologics capacity at its facility in Berkeley, CA.
March 08, 2018
GlobalData reports the need to shift away from egg-based manufacturing of vaccines in light of influenza-related deaths.
Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.
February 23, 2018
The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.
February 22, 2018
The new training center, the Jefferson Institute for Bioprocessing, will prepare engineering students and industry professionals for the field of biologics manufacturing.